Procter & Gamble (NYSE:PG) Stock Price Target Raised at JPMorgan Chase & Co.

Procter & Gamble (NYSE:PG – Get Free Report) had its price objective lifted by investment analysts at JPMorgan Chase & Co. from $162.00 to $180.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 11.72% from the stock’s previous close.

Several other equities research analysts have also recently commented on the company. Morgan Stanley boosted their price target on Procter & Gamble from $166.00 to $185.00 and gave the company an “overweight” rating in a research note on Friday. Argus cut Procter & Gamble from a “buy” rating to a “hold” rating in a report on Friday, August 7th. Wells Fargo & Company raised their price target on Procter & Gamble from $164.00 to $180.00 and gave the company an “overweight” rating in a report on Friday. UBS Group set a $190.00 price target on Procter & Gamble in a report on Friday. Finally, Evercore raised Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 price objective for the company in a report on Tuesday, October 6th. Fourteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $167.00.

Check Out Our Latest Analysis on PG

Procter & Gamble Price Performance

Shares of PG stock traded down $4.47 during trading hours on Friday, hitting $161.12. The company’s stock had a trading volume of 3,374,824 shares, compared to its average volume of 9,732,704. The stock has a market cap of $374.24 billion, a price-to-earnings ratio of 24.34, a P/E/G ratio of 3.90 and a beta of 0.39. The business has a fifty day moving average of $148.08 and a 200-day moving average of $146.99. Procter & Gamble has a twelve month low of $137.62 and a twelve month high of $167.25. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43.

Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating the consensus estimate of $1.89 by $0.11. The firm had revenue of $23.28 billion for the quarter, compared to analyst estimates of $22.80 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. Procter & Gamble’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.99 earnings per share. As a group, equities research analysts anticipate that Procter & Gamble will post 6.98 EPS for the current year.

Insiders Place Their Bets

In other news, CFO Andre Schulten sold 3,914 shares of the stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $568,860.76. Following the transaction, the chief financial officer directly owned 65,618 shares of the company’s stock, valued at $9,536,920.12. This represents a 5.63% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Matthew Janzaruk sold 359 shares of the stock in a transaction on Monday, August 24th. The stock was sold at an average price of $145.24, for a total value of $52,141.16. Following the completion of the sale, the chief accounting officer owned 1,271 shares of the company’s stock, valued at $184,600.04. The trade was a 22.02% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 15,135 shares of company stock valued at $2,189,970. 0.23% of the stock is owned by company insiders.

Institutional Trading of Procter & Gamble

Several institutional investors have recently modified their holdings of the stock. Baxter Bros Inc. purchased a new stake in Procter & Gamble during the second quarter worth approximately $12,381,000. Empowered Funds LLC bought a new stake in Procter & Gamble during the 2nd quarter valued at approximately $53,549,000. Bank of America Corp DE bought a new position in Procter & Gamble during the second quarter worth about $3,850,628,000. Rokos Capital Management LLP acquired a new stake in shares of Procter & Gamble in the first quarter valued at $29,914,000. Finally, State Street Corp boosted its stake in shares of Procter & Gamble by 1.0% in the 2nd quarter. State Street Corp now owns 102,216,308 shares of the company’s stock valued at $14,988,999,000 after purchasing an additional 965,461 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Sales and earnings exceeded expectations. Fiscal first-quarter EPS was $2.00 versus the $1.89 consensus, while revenue rose 4% year over year to $23.28 billion, ahead of estimates. Procter & Gamble earnings beat as sales rise 4%
  • Positive Sentiment: Underlying demand improved. Organic sales grew 4%, with volume contributing 2.4 percentage points. Strength in laundry, home-care products and favorable product mix helped offset pressure on consumers and supported operating leverage. Procter & Gamble: 3 Key Takeaways for Long-Term Investors
  • Positive Sentiment: Analyst sentiment and the sales outlook improved. TD Cowen raised its price target from $150 to $166 while maintaining a Hold rating. P&G also lifted its fiscal 2027 all-in sales-growth outlook, partly reflecting the Thorne acquisition.
  • Neutral Sentiment: Management remains focused on resilience and productivity. The company said consumer demand remains solid and expects productivity savings and mix benefits to aid profitability, but the full-year outlook leaves limited room for further upside. Procter & Gamble: Improving Operating Leverage
  • Negative Sentiment: Commodity, energy and transportation costs are rising. P&G warned that higher input costs could create an approximately $1.4 billion annual headwind, pressuring margins and potentially offsetting sales gains. P&G flags bigger hit to annual profit
  • Negative Sentiment: Guidance creates uncertainty. Fiscal 2027 revenue guidance of $86.0 billion-$87.7 billion is below the $88.8 billion consensus, while margins remain under pressure. After the recent surge toward a 52-week high, profit-taking and concerns about valuation may be weighing on PG.

Procter & Gamble Company Profile

(Get Free Report)

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

Featured Articles

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.